Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
about
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsINTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologistCorrelation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunctionNatriuretic Peptide testing in primary careInsulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediatorPrognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function.Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons.Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.B-type natriuretic peptide-guided therapy for perioperative medicine?The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assaysB-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gainThe association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.Recent advances in natriuretic peptide researchPredictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.Blood-borne biomarkers of mortality risk: systematic review of cohort studies.Progression of left ventricular diastolic dysfunction and risk of heart failure.NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population.Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritisEvaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?Identifying early cardiovascular disease to target candidates for treatment.The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsThe relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findings.N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification.Natriuretic peptides in the diagnosis and management of chronic heart failure.N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysisThe paradox of low BNP levels in obesity.In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
P2860
Q26778333-9D181DC9-2949-455C-9C29-44FE7C046948Q28083473-0843CD25-B1DA-49DA-B668-AD050E5EF0BEQ28601952-78C1C9FB-F073-46A1-9A11-15C55B040AA0Q33572286-A67E4939-0700-4BBC-A8E0-CA33DB88E035Q33671233-D55EFC0C-99F0-4071-8CE8-FAFD738823EBQ33706264-2D379376-F03B-4AD7-A44A-63C1766BE878Q33733517-CED41EB6-8515-4335-B72F-016728E03067Q33918896-2167D882-3F8A-4C93-868F-76370235DF85Q33948944-E5FD6553-0263-443E-8953-5095DA5BFBC1Q33994980-8F6FD2B2-C802-4962-8F1B-CCD5A3DD6A1AQ34181625-82DB4AA1-B31B-4BD0-BDE8-D49D1C9C9CECQ34304406-1FC376B9-06C7-48AF-B0AB-0379F271F754Q34616035-F33B58A3-59B2-444F-AAAF-61F52C736F2EQ35026256-30E626AA-4EC8-4E87-9C48-C7CB70885BB6Q35034900-FD5D8B0E-E424-407F-B22D-3BC7285CE530Q35216649-EC772B38-454C-411C-A8C7-C429DFA693E1Q35287950-5DB5EFC4-6290-4C0E-AB71-9B6307A7E3BFQ35459776-51A88FA1-0208-4F37-A6A4-C87899B5EAB7Q35586340-BE774991-F58E-4CDD-9A88-6B5B95B9098CQ35651148-B68A33C6-E55A-4148-B53A-C736DBF4942BQ35719757-0BADC218-896A-4866-A77D-19B51CF20E89Q36155133-AE9695BE-D10B-4AAC-B459-AA8F6C937666Q36385601-920CC6D5-D687-4E0A-AD41-872942B91DEDQ36407050-697EFC02-0050-49BA-922B-D788771EA14FQ36433506-2C05C781-2388-4918-BAA0-8CDA3BA13FF1Q36666782-C979B064-8A24-43EF-8DF0-C86FEAEC61D3Q36984426-C63F6C77-38AE-4F39-A334-4F16CBB60439Q37004632-CA0647AD-0E6F-4001-97D1-92D134871354Q37097127-9D3612ED-FBA4-4D7F-9446-5F35DF9AC983Q37104528-EBAD29B5-9C4C-46E4-BC43-1A8B7EB0BF26Q37163361-CB40C45B-CC84-4184-ACED-B4C35CB589A4Q37232282-6C31F90C-4DC4-4362-A888-69DD5EE3CB95Q37368214-BDDD9E13-568A-486E-8190-C9A3205B82E3Q37447544-2E75DF43-204E-4C0B-97AE-4DB037FADC81Q37456396-87EAC8BE-38E3-4A9D-8AED-3FE146DB2E44Q37496146-C6FCF8F8-EC21-45B7-933A-9CC0EEDD84E9Q37612412-44B832B9-C2E3-4F2C-8817-BC7092B1C660Q37869374-2A295B5B-976E-42C3-A904-4119D15DA3ACQ38623581-3777498C-283C-4F62-AFAF-879BA87A7CF6Q41548532-DB456BED-2DD1-42B5-A6BF-25D41A62D6A0
P2860
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@en
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@nl
type
label
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@en
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@nl
prefLabel
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@en
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@nl
P2093
P2860
P1433
P1476
Amino-terminal pro-B-type natr ...... cohort free of heart failure.
@en
P2093
Alessandro Cataliotti
Douglas W Mahoney
Fernando L Martin
John C Burnett
Lynn H Urban
Margaret M Redfield
Paul M McKie
Richard J Rodeheffer
P2860
P304
P356
10.1161/01.HYP.0000216794.24161.8C
P407
P577
2006-04-03T00:00:00Z